Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Estrogen Antagonists
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Estrogen Antagonists
Tree Number(s)
D06.347.295
D27.505.696.399.450.327
Unique ID
D004965
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004965
Annotation
do not confuse with
ANTIESTROGENS
see
ESTROGEN RECEPTOR MODULATORS
Scope Note
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.
Entry Version
ESTROGEN ANTAG
Entry Term(s)
Estradiol Antagonists
NLM Classification #
WP 522
Previous Indexing
Estrogens (1966-1977)
specific estrogen (1966-1977)
See Also
Estrogen Receptor Modulators
Estrogens
Public MeSH Note
78
History Note
78
Date Established
1978/01/01
Date of Entry
1999/11/08
Revision Date
2014/06/12
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormone Antagonists [D06.347]
Androgen Antagonists [D06.347.065]
Antithyroid Agents [D06.347.100]
Calcimimetic Agents [D06.347.230]
Estrogen Antagonists [D06.347.295]
Estrogen Receptor Antagonists [D06.347.295.500]
Estrogen Receptor Modulators [D06.347.360]
Insulin Antagonists [D06.347.420]
Leukotriene Antagonists [D06.347.565]
Mineralocorticoid Receptor Antagonists [D06.347.700]
Prostaglandin Antagonists [D06.347.710]
Puberty Inhibitors [D06.347.855]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormone Antagonists [D27.505.696.399.450]
Androgen Antagonists [D27.505.696.399.450.065]
Antithyroid Agents [D27.505.696.399.450.100]
Calcimimetic Agents [D27.505.696.399.450.230]
Estrogen Antagonists [D27.505.696.399.450.327]
Aromatase Inhibitors [D27.505.696.399.450.327.149]
Estrogen Receptor Antagonists [D27.505.696.399.450.327.650]
Estrogen Receptor Modulators [D27.505.696.399.450.360]
Insulin Antagonists [D27.505.696.399.450.420]
Leukotriene Antagonists [D27.505.696.399.450.565]
Mineralocorticoid Receptor Antagonists [D27.505.696.399.450.600]
Prostaglandin Antagonists [D27.505.696.399.450.710]
Puberty Inhibitors [D27.505.696.399.450.783]
Steroid Synthesis Inhibitors [D27.505.696.399.450.855]
Expand All
Collapse All
Estrogen Antagonists
Preferred
Concept UI
M0007791
Scope Note
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.
Terms
Estrogen Antagonists
Preferred Term
Term UI
T015153
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1978)
Estradiol Antagonists
Narrower
Concept UI
M0007777
Scope Note
Compounds which inhibit or antagonize the biosynthesis or action of estradiol.
Terms
Estradiol Antagonists
Preferred Term
Term UI
T015130
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1978)
page delivered in 0.145s